Seoul Semiconductor Launches Auctions for Key Technology Patent Portfolios for 5G Network Design and Smartphone Cameras
Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), a leading global innovator of LED products and technology, announced that it will auction its radio frequency (RF) semiconductor patent portfolio and its high power LED package patent portfolio.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191126005105/en/
Seoul Semiconductor launches patent auctions with GoodIP, a digital licensing platform (Graphic: Business Wire)
In the first auction, Seoul Semiconductor is seeking the top bidder for 98 patent assets related to power amplifiers and gallium nitride (GaN) RF semiconductors, including 55 U.S. patents. Three of the patents are licensed to the U.S. Air Force or the U.S. Army, confirming the value of the portfolio.
This RF patent portfolio is the result of an investment of more than $100 million in R&D by Sensor Electronic Technology, Inc. (SETi), which was founded in 1999 at the Rensselaer Polytechnic Institute (RPI) in New York. SETi, which was completely acquired by Seoul Viosys in 2015, one of the affiliates of Seoul Semiconductor, was at the forefront of GaN device development for high power RF and UV LED technologies. SETi is now focused on UV LED technologies, thus its GaN RF patent portfolio is being auctioned.
GaN has a wider bandgap than silicon, which means it can sustain higher voltages than silicon, and is able to carry current through the device faster. GaN is becoming the technology of choice for mobile and satellite communications, radar, wireless charging and autonomous driving.
With 5G implementation coming soon, the GaN RF market is developing fast. The GaN RF market will grow to USD 2 billion by 2024 (Yole Développement, 2019) and the global radio frequency components market size is expected to reach USD 45 billion by 2025 (published in Market Research Report, 2019). The companies Sumitomo Chemical Co., Cree Inc., and Qorvo, Inc. hold a large share of the GaN RF market.
In the second auction, Seoul Semiconductor will auction more than 100 patents, including US, European, Chinese, Japanese, and Korean patents related to high power LED packages and adaptive lighting. High power LED packages are used in smartphone and automotive applications. Adaptive lighting is used in smartphone camera lenses and flash-lights and automotive headlights. In addition, these are some of the essential patents for high power LED chips enabling thin and small design of lenses and flash-lights to respond to market demands for diverse functions of smartphone camera.
“Seoul Semiconductor is now looking for potential buyers or licensing partners for certain of these technologies. We believe that it can be a good opportunity for startups and small-to-medium enterprises (SMEs), who have difficulty in holding key patents, to expand their business,” said Seoul Semiconductor’s founder Chung Hoon Lee and SETi’s chief executive officer Chae Hon Kim.
“Meanwhile, some large companies have negatively affected the LED industry by having unlawful access to our trade secrets by soliciting employees or preferring low-cost products that ignore intellectual property rights. As a part of our new patent management strategy, we will sell some of our patents to companies that do not compete directly, and will invest the profits from the auction to develop new technologies in the future,” added Lee and Kim.
The auction process is being handled by GoodIP, the digital licensing platform that helps tech companies and research centers identify licensing partners for their intellectual property.
GoodIP helps tech companies and research centers identify licensing partners for their intellectual property through GoodIP’s digital licensing platform. GoodIP is supported by Fluxunit/Osram Ventures and the LMU Entrepreneurship Center. For more information, please visit www.goodip.io.
About Seoul Semiconductor
Seoul Semiconductor develops and commercializes LEDs for automotive, general illumination, specialty lighting, and backlighting markets. As the second-largest LED manufacturer globally excluding the captive market, Seoul Semiconductor holds more than 14,000 patents, offers a wide range of technologies, and mass produces innovative LED products such as SunLike – delivering the world’s best light quality in a next-generation LED enabling human-centric lighting optimized for circadian rhythms; WICOP – a simpler structured package-free LED which provides market leading color uniformity and cost savings at the fixture level, providing high lumen density and design flexibility; NanoDriver Series – the world’s smallest 24W DC LED drivers; Acrich, the world's first high-voltage AC-driven LED technology developed in 2005, including all AC LED-related technologies from chip to module and circuit fabrication, and nPola, a new LED product based on GaN-substrate technology that achieves more than ten times the output of conventional LEDs. UCD constitutes a high color gamut display which delivers more than 90% NTSC. For more information, please visit www.seoulsemicon.com/en.
CEO Bastian July
Seoul Semiconductor Co., Ltd.
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
HighRes Biosolutions and Novo Nordisk partner to transform drug discovery in automated Lab of the Future24.1.2020 17:00:00 EET | Press release
HighRes Biosolutions and Novo Nordisk A/S today announced that they will collaborate to design a state-of-the-art robotic platform for high-throughput biologics engineering and characterisation. The integration of a multi-system robotics platform with sophisticated software control architecture will enable a digital transformation and accelerated discovery for Novo Nordisk’s peptide and large molecule therapeutics research. “In order to maintain our leadership within biologics engineering we are investing in a fully automated and digital design platform. This investment is linked to our build-up in AI and advanced analytics and demonstrates Novo Nordisk’s commitment as a world leading biologics research company,” said Lars Fogh Iversen, senior vice president, Global Research Technologies, Novo Nordisk. The platform will comprise several highly automated and integrated cells for production, characterisation and functional analysis of thousands of biologic compounds every month. Its scop
Conquest Invests in 5 Greenfield Onshore Wind Parks Totalizing 43MW in the Flanders Region24.1.2020 15:37:00 EET | Press release
Conquest, acting through the Conquest Sustainable Infrastructure fund, announced the transaction was closed after an exclusive agreement had been reached with ENGIE Electrabel. Conquest acquires 51% of a portfolio expected to provide 111 GWh per annum of renewable power representing the annual electricity consumption of about 32,000 Belgian homes from early 2021 onwards. The projects benefit from 15 to 20-year green certificates local remuneration schemes, and thus generate yearly secured revenues. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200124005221/en/ Credit: Electrabel While the energy and digital transitions continue to drive the infrastructure sector, Conquest keeps building its diversified sustainable real asset portfolio in Western European markets. The success lies in years of collaboration and long-lasting partnerships with fellow industry experts who can notably facilitate access to new growth opportunities
Fluence Expands EMEA Footprint with Horticulture Partners in Papenburg, Germany24.1.2020 14:00:00 EET | Press release
Fluence by OSRAM (Fluence), a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and agriculture production, announced today it is expanding its presence in the Emsland region of Germany through partnerships with growers and other horticulture specialists operating out of Papenburg. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200124005109/en/ Friedrich Schulz’s 5.5 hectare farm—which grows herbs year-round in addition to lettuce, peppers and chives—utilizing VYPR 2p fixtures. (Photo: Business Wire) Given Papenburg’s decades-long history of attracting horticulture experts, Fluence’s innovative lighting solutions for horticulture are a natural fit for the region’s tomato, cucumber, leafy greens and herb growers. Forging connections with Papenburg’s horticultural leaders Elektro Evers, an engineering firm specializing in greenhouse technology, is Fluence’s exclusive systems integrator
HCL Technologies Honors Global Goodwill Champions at the 2020 World Economic Forum in Davos24.1.2020 12:47:00 EET | Press release
HCL Technologies (HCL), a leading global technology company, today presented its Wave Maker Awards 2020, commemorating global goodwill champions from around the world. The award ceremony, which was held at the HCL Pavilion in Davos, celebrated organizations and individuals passionately committed to such noble causes as diversity & inclusion, education & community upliftment, environment & sustainability, and technology for change. Special guest at the awards was Australian cricket legend Glenn McGrath, who is also founder of the McGrath Foundation, which provides support for Australian women diagnosed with breast cancer and their families. The award recipients were; Lois Auta, Founder and Executive Director of Cedar Seed Foundation, which supports persons with disabilities to participate in all aspects of life; Chido Govera, Founder and Director of The Future of Hope Foundation (TFoHF), which supports marginal and vulnerable members of society through entrepreneurial and self-developme
Ipsen’s palovarotene clinical program in fibrodysplasia ossificans progressiva reaches prespecified interim analysis futility criteria24.1.2020 09:00:00 EET | Press release
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced the decision to pause dosing patients in the global Phase III (PVO-1A-301) study designed to evaluate the efficacy and safety of palovarotene in patients with fibrodysplasia ossificans progressiva (FOP), as well as the ongoing Phase II (PVO-1A-202/204) extension studies. In both the Phase III and Phase II extension studies, palovarotene is dosed both chronically (daily) and episodically (during flare-ups). The decision to pause dosing patients in the trial is based on results of a futility analysis reviewed by the Independent Data Monitoring Committee (IDMC) as part of the prespecified interim analysis. The results of a futility analysis indicated that the Phase III FOP trial was unlikely to meet its primary efficacy endpoint (annualized change in new HO volume as compared with Natural History Studyi) upon completion. Despite the results of the prespecified interim analysis, signals of encouraging therapeutic activity w
Amazentis Announces the Launch of Timeline™ Cellular Nutrition at the World Economic Forum in Davos23.1.2020 23:56:00 EET | Press release
Amazentis announces the debut of Timeline, a next generation nutrition product designed to promote healthy aging, as part of the Swiss Food & Nutrition Valley in the House of Switzerland at the World Economic Forum in Davos, Switzerland. Given the increase in the aging population globally -- according to a 2019 Deutsche Bank study, there are more people on Earth older than sixty five than younger than five for the first time -- it is imperative for consumers to take proactive measures to maintain a high quality of life, for as long as they live. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200123005820/en/ (Photo: Business Wire) Timeline contains the proprietary nutrient Mitopure™, a highly pure form of Urolithin A. After a decade of rigorous research by leading scientists around the world, Mitopure has been shown to help counter age-associated cellular and muscular decline by revitalizing the mitochondria, the powerplants
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom